Sedana Medical AB (publ), Interim report Q3, 2019
Strong sales growth and good progress towards registrationFinancial summary, July - September · Net sales during the third quarter amounted to KSEK 16,416 (12,682) corresponding to an increase of 29% compared with the same period in 2018. · Earnings before interest, taxes, depreciation and amortisation (EBITDA) amounted to KSEK -4,029 (-964) KSEK. This corresponds to an EBITDA margin of -25% (-8%). · Earnings before interest and taxes (EBIT) amounted to KSEK -5,093 (-2,051), which corresponds to an EBIT margin of -31% (-16%). · Cash flow from operations before changes in